Curated insights • How it Works • Practical Pearls • Evidence Base
The criteria should only be applied if synovitis is not better explained by another disease (e.g., SLE, Psoriatic Arthritis, Gout, CPPD). If the patient has typical erosions on X-ray, RA can be diagnosed without further scoring.
| 1 large joint |
| 2–10 large joints |
| 1–3 small joints |
| 4–10 small joints |
| > 10 joints (at least 1 small joint) |
| Negative RF and Negative ACPA |
| Low-positive RF or Low-positive ACPA |
| High-positive RF or High-positive ACPA |
| Normal CRP and Normal ESR |
| Abnormal CRP or Abnormal ESR |
| < 6 weeks |
| ≥ 6 weeks |
A total score of ≥ 6/10 is required for classification of "Definite RA".
Unlike the 1987 criteria, which prioritized chronic, erosive disease (late-stage RA), the 2010 criteria focus on early detection to prevent joint damage. "High-positive" is defined as > 3x the upper limit of normal (ULN).
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: ADRB phase 2 studies.
The 2010 criteria were developed through a complex process involving a European (EULAR) and North American (ACR) collaboration. The committee used a three-phase approach: a data-driven phase based on actual patient cohorts, a consensus-driven phase using expert scenarios, and a final validation phase.
The inclusion of ACPA (anti-cyclic citrullinated peptide antibody) was the most significant biological advancement over the older 1987 system, as it has superior specificity (~95%) and prognostic value for radiographic progression compared to Rheumatoid Factor.
Curated insights • How it Works • Practical Pearls • Evidence Base
The criteria should only be applied if synovitis is not better explained by another disease (e.g., SLE, Psoriatic Arthritis, Gout, CPPD). If the patient has typical erosions on X-ray, RA can be diagnosed without further scoring.
| 1 large joint |
| 2–10 large joints |
| 1–3 small joints |
| 4–10 small joints |
| > 10 joints (at least 1 small joint) |
| Negative RF and Negative ACPA |
| Low-positive RF or Low-positive ACPA |
| High-positive RF or High-positive ACPA |
| Normal CRP and Normal ESR |
| Abnormal CRP or Abnormal ESR |
| < 6 weeks |
| ≥ 6 weeks |
A total score of ≥ 6/10 is required for classification of "Definite RA".
Unlike the 1987 criteria, which prioritized chronic, erosive disease (late-stage RA), the 2010 criteria focus on early detection to prevent joint damage. "High-positive" is defined as > 3x the upper limit of normal (ULN).
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: ADRB phase 2 studies.
The 2010 criteria were developed through a complex process involving a European (EULAR) and North American (ACR) collaboration. The committee used a three-phase approach: a data-driven phase based on actual patient cohorts, a consensus-driven phase using expert scenarios, and a final validation phase.
The inclusion of ACPA (anti-cyclic citrullinated peptide antibody) was the most significant biological advancement over the older 1987 system, as it has superior specificity (~95%) and prognostic value for radiographic progression compared to Rheumatoid Factor.
